RxDoctor Payments Data

Raya Galibov

Physician Assistant · New York, NYNPI 1912008855

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $19,318 of the $27,695 with a category attached, or 69.8%. 60 manufacturers reported payments, led by Intuity Medical Inc at 30.9% of the total. Reporting peaked in 2023 at $10,111 and has fallen 60.1% since, to $4,033 in 2025. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,695in general payments, 2019–2025

Across 786 payments — averaging $35.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuity Medical Inc$9K
  • AstraZeneca$3K
  • Lilly USA, LLC$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Sanofi-aventis U.S. LLC$1K
  • plus $10K from 54 others

What the payments were for

  • Consulting fees$5952%
  • Speaking & faculty fees$7,70028%
  • Food & beverage$19,31870%
  • Education$820%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuity Medical Inc22$8,566
AstraZeneca(2 entities)102$2,913
Lilly USA, LLC112$2,390
AbbVie97$2,079
Novo Nordisk50$1,110
Sanofi-aventis U.S. LLC44$1,043
Mannkind Corporation32$988
Bayer32$740
BETA Bionics, Inc.14$686
Amgen(2 entities)29$636
Pfizer17$393
Astellas Pharma US Inc13$367
Boehringer Ingelheim13$360
Ascensia Diabetes Care US Inc.12$339
Antares Pharma, Inc.14$335
Dexcom, Inc.9$314
Idorsia Pharmaceuticals US Inc12$273
Biohaven Pharmaceuticals, Inc.6$264
Exact Sciences9$242
Xeris Pharmaceuticals, Inc.11$235
Kyowa Kirin, Inc.11$205
Verity Pharmaceuticals Inc.8$196
Abbott8$186
Amneal Pharmaceuticals LLC8$177
Radius Health, Inc.6$154
Althera Pharmaceuticals LLC1$153
Lifescan, Inc.6$151
IBSA Pharma Inc.7$150
Insulet Corporation5$147
Acella Pharmaceuticals, LLC6$130
Phathom Pharmaceuticals, Inc.1$125
Intra-sana Laboratories5$113
Biohaven Pharmaceutical Holding Company Ltd.4$109
Medtronic4$107
Corcept Therapeutics4$105
Cequr Corporation4$103
Ascendis Pharma Endocrinology Inc4$102
Esperion Therapeutics, Inc.4$91
Acerus Pharmaceuticals Corporation3$68
Merck3$67
Kowa Pharmaceuticals America, Inc.2$61
Amarin Pharma, Inc.3$60
Novartis2$58
Neurocrine Biosciences, Inc.2$57
GSK3$57
Vistapharm, Inc.3$56
Halozyme Inc2$54
Madrigal Pharmaceuticals2$52
Recordati_rare_diseases_inc.2$48
Zealand Pharma US, Inc.2$46
Currax Pharmaceuticals LLC2$32
Eisai Inc.1$32
Tandem Diabetes Care, Inc.1$24
Clarus Therapeutics Inc.1$22
Lundbeck LLC1$22
Vivus LLC1$21
Chiesi USA, Inc.1$21
Avion Pharmaceuticals1$21
Tolmar, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,695 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide154$230,229
JardianceEmpagliflozin93$110,927
MounjaroTirzepatide52$95,725
FarxigaDapagliflozin Propanediol54$63,251
Tresiba Flextouch U-200Insulin Degludec29$37,200
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/729$34,892
Tresiba Flextouch U-100Insulin Degludec37$32,359
TrulicityDulaglutide15$31,890
JanuviaSitagliptin Phosphate34$31,669
Janumet XrSitagliptin Phos/Metformin Hcl23$29,582
TradjentaLinagliptin25$26,524
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$21,480
Bydureon BciseExenatide Microspheres12$19,539
Novolog FlexpenInsulin Aspart43$13,498
Testosterone19$11,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$1,110$234,681170 claims
Boehringer IngelheimJardiance, Tradjenta$360$137,451118 claims
Lilly USA, LLCMounjaro, Trulicity$2,390$127,61567 claims
AstraZenecaFarxiga$2,913$63,25154 claims
MerckJanuvia, Janumet Xr$67$61,25157 claims
AbbVieSynthroid$2,079$1,81119 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$177$1,471102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →